185 related articles for article (PubMed ID: 35246941)
1. The NF1 microdeletion syndrome: early genetic diagnosis facilitates the management of a clinically defined disease.
Kehrer-Sawatzki H; Bäzner U; Krämer J; Lewerenz J; Pfeiffer C
J Dtsch Dermatol Ges; 2022 Mar; 20(3):273-277. PubMed ID: 35246941
[TBL] [Abstract][Full Text] [Related]
2. NF1 microdeletion syndrome: case report of two new patients.
Serra G; Antona V; Corsello G; Zara F; Piro E; Falsaperla R
Ital J Pediatr; 2019 Nov; 45(1):138. PubMed ID: 31703719
[TBL] [Abstract][Full Text] [Related]
3. NF1 microdeletion syndrome: a phenotypical characterization of a rare case of neurofibromatosis type 1.
Lopes J; Teixeira D; Sousa C; Baptista A; Osório Ferreira E
Acta Dermatovenerol Alp Pannonica Adriat; 2020 Jun; 29(2):85-87. PubMed ID: 32566957
[TBL] [Abstract][Full Text] [Related]
4. Development of a multidisciplinary clinic of neurofibromatosis type 1 and other neurocutaneous disorders in Greece. A 3-year experience.
Kokkinou E; Roka K; Alexopoulos A; Tsina E; Nikas I; Krallis P; Thanopoulou I; Nasi L; Makrygianni E; Tsoutsou E; Kosma K; Tsipi M; Tzetis M; Frysira H; Kattamis A; Pons R
Postgrad Med; 2019 Sep; 131(7):445-452. PubMed ID: 31443616
[TBL] [Abstract][Full Text] [Related]
5. Emerging genotype-phenotype relationships in patients with large NF1 deletions.
Kehrer-Sawatzki H; Mautner VF; Cooper DN
Hum Genet; 2017 Apr; 136(4):349-376. PubMed ID: 28213670
[TBL] [Abstract][Full Text] [Related]
6. Analysis of neurofibromatosis 1 (NF1) lesions by body segment.
Palmer C; Szudek J; Joe H; Riccardi VM; Friedman JM
Am J Med Genet A; 2004 Mar; 125A(2):157-61. PubMed ID: 14981716
[TBL] [Abstract][Full Text] [Related]
7. An Update on Neurofibromatosis Type 1: Not Just Café-au-Lait Spots and Freckling. Part II. Other Skin Manifestations Characteristic of NF1. NF1 and Cancer.
Hernández-Martín A; Duat-Rodríguez A
Actas Dermosifiliogr; 2016; 107(6):465-73. PubMed ID: 26956402
[TBL] [Abstract][Full Text] [Related]
8. Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome.
Messiaen L; Yao S; Brems H; Callens T; Sathienkijkanchai A; Denayer E; Spencer E; Arn P; Babovic-Vuksanovic D; Bay C; Bobele G; Cohen BH; Escobar L; Eunpu D; Grebe T; Greenstein R; Hachen R; Irons M; Kronn D; Lemire E; Leppig K; Lim C; McDonald M; Narayanan V; Pearn A; Pedersen R; Powell B; Shapiro LR; Skidmore D; Tegay D; Thiese H; Zackai EH; Vijzelaar R; Taniguchi K; Ayada T; Okamoto F; Yoshimura A; Parret A; Korf B; Legius E
JAMA; 2009 Nov; 302(19):2111-8. PubMed ID: 19920235
[TBL] [Abstract][Full Text] [Related]
9. A novel NF1 mutation in a Chinese patient with giant café-au-lait macule in neurofibromatosis type 1 associated with a malignant peripheral nerve sheath tumor and bone abnormality.
Tong HX; Li M; Zhang Y; Zhu J; Lu WQ
Genet Mol Res; 2012 Aug; 11(3):2972-8. PubMed ID: 22869071
[TBL] [Abstract][Full Text] [Related]
10. Genotype-phenotype associations in neurofibromatosis type 1 (NF1): an increased risk of tumor complications in patients with NF1 splice-site mutations?
Alkindy A; Chuzhanova N; Kini U; Cooper DN; Upadhyaya M
Hum Genomics; 2012 Aug; 6(1):12. PubMed ID: 23244495
[TBL] [Abstract][Full Text] [Related]
11. Café-au-lait Macules and Neurofibromatosis Type 1: A Review of the Literature.
Bernier A; Larbrisseau A; Perreault S
Pediatr Neurol; 2016 Jul; 60():24-29.e1. PubMed ID: 27212418
[TBL] [Abstract][Full Text] [Related]
12. Atypical Café-au-Lait Macules in a Patient with Koolen-de Vries Syndrome (17q21.31 Microdeletion Syndrome).
Han AM; Kusari A; Soeprono F; Eichenfield LF
Pediatr Dermatol; 2019 Jul; 36(4):e97-e98. PubMed ID: 31125459
[TBL] [Abstract][Full Text] [Related]
13. Classification of NF1 microdeletions and its importance for establishing genotype/phenotype correlations in patients with NF1 microdeletions.
Kehrer-Sawatzki H; Cooper DN
Hum Genet; 2021 Dec; 140(12):1635-1649. PubMed ID: 34535841
[TBL] [Abstract][Full Text] [Related]
14. Genetic analyses of mosaic neurofibromatosis type 1 with giant café-au-lait macule, plexiform neurofibroma and multiple melanocytic nevi.
Hida T; Idogawa M; Okura M; Sugita S; Sugawara T; Sasaki Y; Tokino T; Yamashita T; Uhara H
J Dermatol; 2020 Jun; 47(6):658-662. PubMed ID: 32246533
[TBL] [Abstract][Full Text] [Related]
15. Clinical and molecular characterization of 112 single-center patients with Neurofibromatosis type 1.
Corsello G; Antona V; Serra G; Zara F; Giambrone C; Lagalla L; Piccione M; Piro E
Ital J Pediatr; 2018 Apr; 44(1):45. PubMed ID: 29618358
[TBL] [Abstract][Full Text] [Related]
16. Neurofibromatosis without Neurofibromas: Confirmation of a Genotype-Phenotype Correlation and Implications for Genetic Testing.
Quintáns B; Pardo J; Campos B; Barros F; Volpini V; Carracedo A; Sobrido MJ
Case Rep Neurol; 2011 Apr; 3(1):86-90. PubMed ID: 21532985
[TBL] [Abstract][Full Text] [Related]
17. An Update on Neurofibromatosis Type 1: Not Just Café-au-Lait Spots, Freckling, and Neurofibromas. An Update. Part I. Dermatological Clinical Criteria Diagnostic of the Disease.
Hernández-Martín A; Duat-Rodríguez A
Actas Dermosifiliogr; 2016; 107(6):454-64. PubMed ID: 26979265
[TBL] [Abstract][Full Text] [Related]
18. Genetic basis of neurofibromatosis type 1 and related conditions, including mosaicism.
Legius E; Brems H
Childs Nerv Syst; 2020 Oct; 36(10):2285-2295. PubMed ID: 32601904
[TBL] [Abstract][Full Text] [Related]
19. A novel MEIS2 mutation explains the complex phenotype in a boy with a typical NF1 microdeletion syndrome.
Santoro C; Riccio S; Palladino F; Aliberti F; Carotenuto M; Zanobio M; Peduto C; Nigro V; Perrotta S; Piluso G
Eur J Med Genet; 2021 May; 64(5):104190. PubMed ID: 33722742
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
